Compare

NewcelX Ltd. vs Curanex Pharmaceuticals Inc vs Revelation Biosciences, Inc. vs MetaVia Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	NewcelX Ltd. NCEL	Curanex Pharmaceuticals Inc CURX	Revelation Biosciences, Inc. REVB	MetaVia Inc. MTVA
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$8.30M	-$4.23M	-$8.91M	-$12.97M
EPS (Diluted)	$2.16	-$0.17	-$23.95	-$7.35
Operating cash flow	-$2.77M	-$10.48M	-$8.27M	-$15.70M
Free cash flow	-$2.77M	n/a	n/a	-$15.70M
Cash & equivalents	$2.20M	$5.00M	$10.70M	$10.28M
Total assets	$11.45M	$11.58M	$11.58M	$11.12M
Total liabilities	$4.20M	$361.0K	$2.72M	$5.79M
Shareholders' equity	$7.25M	$11.22M	$8.86M	$5.33M
Return on year-end equity	-114.5%	-37.7%	-100.6%	-243.3%
Shares outstanding	4.80M	28.34M	1.58M	2.31M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	NewcelX Ltd.	Curanex Pharmaceuticals Inc	Revelation Biosciences, Inc.	MetaVia Inc.
Latest	n/a	n/a	n/a	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a